Pharmafile Logo
Pharmafocus logo
Advanced Search

Purdue Pharma

Showing 10 posts of 25 posts found.

920x920

Opioid drugmaker Purdue Pharma inks deal with Alivio over non-opioid inflammation drug

January 29, 2019
Manufacturing and Production Alivio, Purdue Pharma, health, inflammation, opioids

Opioid drugmaker Purdue Pharma has entered into an agreement with inflammatory disease specialist Alivio Therapeutics for the development of the …

News
920x920

Sacklers accused of personally directing deceptive OxyContin sales tactics

January 17, 2019
Sales and Marketing OxyContin, Purdue Pharma, opidois, opioid crisis, pain, sackler

Members of the billionaire Sackler dynasty personally directed efforts to mislead doctors and patients as to the dangers of the …

News

Purdue-owning Sackler family own second opioid drug maker, FT reveals

September 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing OxyContin, Purdue Pharma, opioid, opioid crisis, sackler

The billionaire Sackler family, the owners of OxyContin drugmaker Purdue Pharma, have been revealed to own a second opioid drug …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 17, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, CMO, Litigation, OxyContin, Purdue Pharma, approvals, top 10

This week’s pharmaceutical headlines were dominated by legal spats as the state of New York sued OxyContin drug maker Purdue …

News
920x920

Purdue culls 350 positions, eradicates sales force

June 21, 2018
Medical Communications, Sales and Marketing Purdue Pharma, opioid crisis, opioids, pharma

Bowing to the pressure applied by external groups for the part it has played in the ongoing opioid crisis, Purdue …

News
pills-384846_960_720

Purdue pulls plug on opioid marketing

February 13, 2018
Manufacturing and Production, Sales and Marketing Purdue Pharma, biotech, drugs, opioid, opioid epidemic, pharma, pharmaceutical

Purdue Pharma was fined $643.5 million in 2007 for its part in creating the opioid epidemic that has plagued the …

News
Gavel

J&J and Purdue settle Kentucky lawsuits for $39.5 million

December 24, 2015
Sales and Marketing Johnson and Johnson, Kentucky, OxyContin, Purdue Pharma, Risperdal, lawsuits

Johnson & Johnson and Purdue Pharma have settled separate lawsuits with the US state of Kentucky for a total of …

News
fda2outsideweb

FDA approves limited OxyContin use in children

August 17, 2015
Sales and Marketing FDA, OxyContin, Purdue, Purdue Pharma, oxycodone

The FDA has approved the limited use of the strong painkiller Oxycontin for children in the US aged between 11 …

News

Pharma companies look to Apple’s ResearchKit for R&D

July 13, 2015
Medical Communications Apple, GSK, Purdue Pharma, R&D, clinical trials, digital health, iOS, iphone, patient engagement, researchkit

Pharma companies are moving into a new area in drug R&D, by using Apple’s ResearchKit platform to gather data from …

News
NIBS image

Manufacturing facilities news in brief

October 7, 2013
Manufacturing and Production Capsugel, Fujifilm Diosynth Biotechnologies, Pfizer, Purdue Pharma, Warner Chilcott

New facilities, plant shutdowns and layoffs in the pharma manufacturing sector.

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026